{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T03:44:26Z","timestamp":1772768666798,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T00:00:00Z","timestamp":1546905600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1038\/s41440-018-0191-5","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T16:20:49Z","timestamp":1546964449000},"page":"801-806","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Efficient screening of patients with aldosterone-producing adenoma using the ACTH stimulation test"],"prefix":"10.1038","volume":"42","author":[{"given":"Toshihiro","family":"Kita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Furukoji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatefumi","family":"Sakae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,8]]},"reference":[{"key":"191_CR1","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1507\/endocrj.KR-105","volume":"54","author":"T Nishikawa","year":"2007","unstructured":"Nishikawa T, Saito J, Omura M. Prevalence of primary aldosteronism: should we screen for primary aldosteronism before treating hypertensive patients with medication? Endocr J. 2007;54:487\u201395.","journal-title":"Endocr J"},{"key":"191_CR2","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005;45:1243\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"191_CR3","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1210\/jc.2008-2116","volume":"94","author":"E Born-Frontsberg","year":"2009","unstructured":"Born-Frontsberg E, Reincke M, Rump LC, Hahner S, Diederich S, Lorenz R, Participants of the German Conn\u2019s Registry. et al. Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn\u2019s Registry. J Clin Endocrinol Metab. 2009;94:1125\u201330.","journal-title":"J Clin Endocrinol Metab"},{"key":"191_CR4","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, PAPY Study Participants. et al. Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension. 2006;48:232\u20138.","journal-title":"Hypertension"},{"key":"191_CR5","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","volume":"58","author":"T Nishikawa","year":"2011","unstructured":"Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, Tamura N, Tanabe A, Task Force Committee on Primary Aldosteronism, The Japan Endocrine Society. Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009. Endocr J. 2011;58:711\u201321.","journal-title":"Endocr J"},{"key":"191_CR6","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101:1889\u2013916.","journal-title":"J Clin Endocrinol Metab"},{"key":"191_CR7","doi-asserted-by":"publisher","first-page":"147032031562570","DOI":"10.1177\/1470320315625703","volume":"17","author":"K Terui","year":"2016","unstructured":"Terui K, Kageyama K, Nigawara T, Moriyama T, Sakihara S, Takayasu S, et al. Evaluation of the (1-24) adrenocorticotropin stimulation test for the diagnosis of primary aldosteronism. J Renin Angiotensin Aldosterone Syst. 2016;17:1470320315625703.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"191_CR8","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1210\/jc.2011-0573","volume":"96","author":"T Sonoyama","year":"2011","unstructured":"Sonoyama T, Sone M, Miyashita K, Tamura N, Yamahara K, Park K, et al. Significance of adrenocorticotropin stimulation test in the diagnosis of an aldosterone-producing adenoma. J Clin Endocrinol Metab. 2011;96:2771\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"191_CR9","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1210\/jc.2014-3551","volume":"100","author":"Y Jiang","year":"2015","unstructured":"Jiang Y, Zhang C, Wang W, Su T, Zhou W, Jiang L, et al. Diagnostic value of ACTH stimulation test in determining the subtypes of primary aldosteronism. J Clin Endocrinol Metab. 2015;100:1837\u201344.","journal-title":"J Clin Endocrinol Metab"},{"key":"191_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1507\/endocrj.EJ16-0297","volume":"64","author":"A Moriya","year":"2017","unstructured":"Moriya A, Yamamoto M, Kobayashi S, Nagamine T, Takeichi-Hattori N, Nagao M, et al. ACTH stimulation test and computed tomography are useful for differentiating the subtype of primary aldosteronism. Endocr J. 2017;64:65\u201373.","journal-title":"Endocr J"},{"key":"191_CR11","doi-asserted-by":"publisher","first-page":"E848","DOI":"10.3390\/ijms18040848","volume":"18","author":"F Buffolo","year":"2017","unstructured":"Buffolo F, Monticone S, Williams TA, Rossato D, Burrello J, Tetti M, et al. Subtype diagnosis of primary aldosteronism: is adrenal vein sampling always necessary? Int J Mol Sci. 2017;18:E848.","journal-title":"Int J Mol Sci"},{"key":"191_CR12","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1530\/EJE-13-0741","volume":"170","author":"S Onozawa","year":"2014","unstructured":"Onozawa S, Murata S, Tajima H, Yamaguchi H, Mine T, Ishizaki A, et al. Evaluation of right adrenal vein cannulation by computed tomography angiography in 140 consecutive patients undergoing adrenal venous sampling. Eur J Endocrinol. 2014;170:601\u20138.","journal-title":"Eur J Endocrinol"},{"key":"191_CR13","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/j.1440-1681.1995.tb02044.x","volume":"22","author":"M Stowasser","year":"1995","unstructured":"Stowasser M, Klemm SA, Tunny TJ, Gordon RD. Plasma aldosterone response to ACTH in subtypes of primary aldosteronism. Clin Exp Pharmacol Physiol. 1995;22:460\u20132.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"191_CR14","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1210\/jcem-28-7-1014","volume":"28","author":"MA Newton","year":"1968","unstructured":"Newton MA, Laragh JH. Effects of glucocorticoid administration on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism. J Clin Endocrinol Metab. 1968;28:1014\u201322.","journal-title":"J Clin Endocrinol Metab"},{"key":"191_CR15","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1172\/JCI107414","volume":"52","author":"DC Kem","year":"1973","unstructured":"Kem DC, Weinberger MH, Gomez-Sanchez C, Kramer NJ, Lerman R, Furuyama S, et al. Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism. J Clin Invest. 1973;52:2272\u20137.","journal-title":"J Clin Invest"},{"key":"191_CR16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1530\/EC-14-0086","volume":"3","author":"T Sonoyama","year":"2014","unstructured":"Sonoyama T, Sone M, Tamura N, Honda K, Taura D, Kojima K, et al. Role of endogenous ACTH on circadian aldosterone rhythm in patients with primary aldosteronism. Endocr Connect. 2014;3:173\u20139.","journal-title":"Endocr Connect"},{"key":"191_CR17","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/cen.12998","volume":"84","author":"H Kobayashi","year":"2016","unstructured":"Kobayashi H, Haketa A, Ueno T, Suzuki R, Aoi N, Ikeda Y, et al. Subtype prediction in primary aldosteronism: measurement of circadian variation of adrenocortical hormones and 24-h urinary aldosterone. Clin Endocrinol (Oxf). 2016;84:814\u201321.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"191_CR18","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1210\/jc.2017-01774","volume":"103","author":"H Umakoshi","year":"2018","unstructured":"Umakoshi H, Tsuiki M, Takeda Y, Kurihara I, Itoh H, Katabami T, JPAS Study Group. et al. Significance of computed tomography and serum potassium in predicting subtype diagnosis of primary aldosteronism. J Clin Endocrinol Metab. 2018;103:900\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"191_CR19","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/hr.2017.78","volume":"40","author":"K Bokuda","year":"2017","unstructured":"Bokuda K, Yatabe M, Mizuguchi Y, Niiyama M, Seki Y, Watanabe D, et al. Body mass index and contralateral ratio predict outcome following unilateral adrenalectomy in primary aldosteronism. Hypertens Res. 2017;40:988\u201393.","journal-title":"Hypertens Res"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41440-018-0191-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-018-0191-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-018-0191-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:20:11Z","timestamp":1684617611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-018-0191-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,8]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["191"],"URL":"https:\/\/doi.org\/10.1038\/s41440-018-0191-5","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,8]]},"assertion":[{"value":"8 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}